OpenURL Connection Search

Select item for more details and to access through your institution.

First-line eradication therapy forHelicobacter pyloriin primary health care based on antibiotic resistance: results of three eradication regimens.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 773, doi. 10.1111/j.1365-2036.2005.02398.x
By:
- Koivisto, T. T.;
- Rautelin, H. I.;
- Voutilainen, M. E.;
- Heikkinen, M. T.;
- Koskenpato, J. P.;
- Färkkilä, M. A.
Publication type:
Article
Cost-effectiveness of thiopurine methyltransferase genotype screening in IBD.
Published in:
2005
By:
- Kitiyakara, T.;
- Hayat, J.;
- McIntyre, A. S.
Publication type:
Letter
Retinal toxicity during pegylatedα-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 723, doi. 10.1111/j.1365-2036.2005.02365.x
By:
- Chisholm, J. A.;
- Williams, G.;
- Spence, E.;
- Parks, S.;
- Keating, D.;
- Gavin, M.;
- Mills, P. R.
Publication type:
Article
Norfloxacin decreases bacterial adherence of quinolone-resistant strains ofEscherichia coliisolated from patients with cirrhosis.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 701, doi. 10.1111/j.1365-2036.2005.02366.x
By:
- Gascón, I.;
- Pascual, S.;
- Plazas, J.;
- Sánchez, J.;
- Francés, R.;
- Más, P.;
- Zapater, P.;
- Pérez‐Mateo, M.;
- Such, J.
Publication type:
Article
Azathioprine-induced pancreatitis in Crohn's disease: a smoking gun or guilt by association. Author's reply.
Published in:
2005
By:
- Weersma, R. K.;
- Peters, F. T. M.;
- Dullemen, H. M.
Publication type:
Letter
IsHelicobacter pyloriseropositivity related to body mass index in the United States?
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 765, doi. 10.1111/j.1365-2036.2005.02369.x
By:
- Ioannou, G. N.;
- Weiss, N. S.;
- Kearney, D. J.
Publication type:
Article
New once-daily, highly effective rescue triple therapy after multipleHelicobacter pyloritreatment failures: a pilot study.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 783, doi. 10.1111/j.1365-2036.2005.02370.x
By:
- Coelho, L. G. V.;
- Moretzsohn, L. D.;
- Vieira, W. L. S.;
- Gallo, M. A.;
- Passos, M. C. F.;
- Cindr, J. M.;
- Cerqueira, M. C.;
- Vitiello, L.;
- Ribeiro, M. L.;
- Mendonça, S.;
- Pedrazzoli‐Júnior, J.;
- Castro, L. P.
Publication type:
Article
Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 709, doi. 10.1111/j.1365-2036.2005.02385.x
By:
- Setchell, K. D. R.;
- Galzigna, L.;
- O'Connell, N.;
- Brunetti, G.;
- Tauschel, H.‐D.
Publication type:
Article
Systematic review: the influence of geography and ethnicity in irritable bowel syndrome.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 663, doi. 10.1111/j.1365-2036.2005.02396.x
By:
- Kang, J. Y.
Publication type:
Article
A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 739, doi. 10.1111/j.1365-2036.2005.02368.x
By:
- Labenz, J.;
- Armstrong, D.;
- Lauritsen, K.;
- Katelaris, P.;
- Schmidt, S.;
- Schütze, K.;
- Wallner, G.;
- Juergens, H.;
- Preiksaitis, H.;
- Keeling, N.;
- Nauclér, E.;
- Eklund, S.
Publication type:
Article
Author's reply.
Published in:
2005
By:
- Winter, J.;
- Shapiro, D.;
- Mills, P. R.
Publication type:
Letter
High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 747, doi. 10.1111/j.1365-2036.2005.02401.x
By:
- Thomas, T.;
- Richards, C. J.;
- Caestecker, J. S.;
- Robinson, R. J.
Publication type:
Article
Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 623, doi. 10.1111/j.1365-2036.2005.02389.x
By:
- Fabrizi, F.;
- Lampertico, P.;
- Lunghi, G.;
- Mangano, S.;
- Aucella, F.;
- Martin, P.
Publication type:
Article
Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 677, doi. 10.1111/j.1365-2036.2005.02391.x
By:
- Bardou, M.;
- Toubouti, Y.;
- Benhaberou‐Brun, D.;
- Rahme, E.;
- Barkun, A. N.
Publication type:
Article
Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders– the clinical evidence.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 633, doi. 10.1111/j.1365-2036.2005.02392.x
By:
- Kuiken, S. D.;
- Tytgat, G. N.;
- Boeckxstaens, G. E.
Publication type:
Article
Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 757, doi. 10.1111/j.1365-2036.2005.02394.x
By:
- Zulu, I.;
- Kelly, P.;
- Njobvu, L.;
- Sianongo, S.;
- Kaonga, K.;
- McDonald, V.;
- Farthing, M.;
- Pollok, R.
Publication type:
Article
Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 653, doi. 10.1111/j.1365-2036.2005.02395.x
By:
- Gisbert, J. P.;
- García‐Buey, L.;
- Pajares, J. M.;
- Moreno‐Otero, R.
Publication type:
Article
The role of transcatheter arterial embolization for patients with unresectable hepatocellular carcinoma: a nationwide, multicentre study evaluated by cancer stage.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 687, doi. 10.1111/j.1365-2036.2005.02404.x
By:
- Huang, Y.‐H.;
- Chen, C.‐H.;
- Chang, T.‐T.;
- Chen, S.‐C.;
- Chiang, J.‐H.;
- Lee, H.‐S.;
- Lin, P.‐W.;
- Huang, G.‐T.;
- Sheu, J.‐C.;
- Tsai, H.‐M.;
- Lee, P.‐C.;
- Huo, T.‐I.;
- Lee, S.‐D.;
- Wu, J.‐C.
Publication type:
Article
Infliximab and the bone in Crohn's disease.
Published in:
2005
By:
- Kunisaki, R.;
- Chaki, O.;
- Taguchi, T.;
- Sugiyama, T.;
- Sugita, A.
Publication type:
Letter
Erratum.
Published in:
2005
Publication type:
Correction Notice
Diagnosis and treatment of autoimmune hepatitis at age 65 and older.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 695, doi. 10.1111/j.1365-2036.2005.02403.x
By:
- Verslype, C.;
- George, C.;
- Buchel, E.;
- Nevens, F.;
- Van Steenbergen, W.;
- Fevery, J.
Publication type:
Article
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 733, doi. 10.1111/j.1365-2036.2005.02405.x
By:
- Mahadevan, U.;
- Kane, S.;
- Sandborn, W. J.;
- Cohen, R. D.;
- Hanson, K.;
- Terdiman, J. P.;
- Binion, D. G.
Publication type:
Article

Found: 22